Usability and Acceptability Study of the P-STEP Mobile Application
| Заболевание | Asthma, Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Coronary Heart Disease |
|---|---|
| Фаза | Не применимо |
| Спонсор | University of Leicester |
| Статус | Завершено |
| Участники | 178 участн. |
| Вмешательство | P-STEP Mobile Application |
| Дата начала | 23.08.2023 |
| Дата завершения | 1.02.2024 |
| Публикация результатов | 1.05.2026 |
Кратко
Assess the usability and acceptance of the P-STEP app, through allowing participants with specific chronic conditions to pilot the app for 12-weeks.
System Usability Scale
| 6-weeks | 57.92 ± 20.12 score on a scale |
|---|---|
| 12-week | 61.68 ± 22.09 score on a scale |
Открыть в BENITIONS Открыть на ClinicalTrials.gov
Другие исследования по этому заболеванию
- Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and — University of Tennessee Graduate School of Medicine
- Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster — Chiesi Farmaceutici S.p.A.
- Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®T — Chiesi Farmaceutici S.p.A.
- Tiotropium/Salmeterol Inhalation Powder in COPD — Boehringer Ingelheim
- Risk Factors, Costs, and Impacts of ED Boarding — University of Maryland, Baltimore
- Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructiv — United Therapeutics